Navigating Reactive Hypoglycemia on Tirzepatide: My Ongoing Journey Without Diabetes
Tirzepatide has been a powerful force in my personal health transformation. This once-weekly GLP-1/GIP receptor agonist is often hailed for its ability to regulate blood sugar and drive meaningful weight loss. But most of the conversation—and most of the clinical data—focuses on people with Type 2 diabetes . Let me be clear right from the start: I do not have diabetes. I do not have Type 2 diabetes. What I do have is reactive hypoglycemia , a condition where my blood sugar crashes after eating—even when I've had a balanced meal. And for people like me, the experience of taking tirzepatide is nuanced. A Rare Side Effect, but Very Real for Some of Us According to studies like SURPASS-4, the incidence of hypoglycemia (defined as <54 mg/dL) on tirzepatide is very low. Only about 1–3% of users not also taking sulfonylureas or insulin experience it. That’s great news—unless you're part of that sliver of the population who does . For me, 12.5 mg of ...